Regeneron Pharmaceuticals Inc at Cowen Health Care Conference Transcript
Okay. Well, good afternoon, everybody or good late morning, and thank you so much for joining us for the 39th annual health care conference at Cowen. And it's a great pleasure to introduce Bob Landry, CFO; and Jay Markowitz, SVP of Portfolio Management for Regeneron.
Questions & Answers
So we have, I think, a fairly aggressive agenda. So we want to talk about financial view for the company over time and the collaboration with Sanofi, and then, obviously, drilling into the pipeline as well. But I think, first, I think it's worthwhile taking a step back and talking about Regeneron broadly as a company and culturally and capability-wise and expertise-wise what makes Regeneron different. And the company was ranked #1 yet again in the biopharma survey. You're the #1 employer. And I know you're both newer to the Regeneron story that's been ongoing for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |